Nalaganje...
Nutlin-3 Enhances Sorafenib Efficacy in Renal Cell Carcinoma
The renal cell carcinoma (RCC) is one of the top ten cancers in USA. The renal tumors are highly angiogenic and are resistant to conventional interventions, particularly radiotherapy. The advent of multispecific tyrosine kinase inhibitor sorafenib has improved the progression-free survival in RCC, b...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2011
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4153352/ https://ncbi.nlm.nih.gov/pubmed/22006587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.20875 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|